For example, serum levels of D-dimer, neuron-specific enolase, and lactate dehydrogenase could be valuable biomarkers to predict survival in SCLC patients (Zhang et al. 2018; Liu et al. 2017). Here, ENO2 is linked to small cell lung carcinoma.